Thrombodynamics- a new global assay for blood clotting monitoring and anticoagulant control.
Thrombodynamics included into the Guidelines for Perioperative Management of Antithrombotic therapy of the FAR, Russia (Federation of anesthesiologists and reanimatologists)HJANUARY 13, 2014 Company news
The all-Russian non-governmental organization «Federation of anesthesiologists and reanimatologists» approved the Guidelines for Perioperative Management of Patients who are Receiving Antithrombotic therapy; the Thrombodynamics assay was included thereto!
On December 16, 2013, HemaCore and the co-investors concluded a transaction which made the company obtain the credit. According to the effective investment contract, the final stage of HemaCore financing is represented by a loan in the amount of 95 million rubles. Several previous stages of financing, the first of which had started on October 14, 2010, were represented by contributions to the registered capital of HemaCore allowing the company to terminate the development and investigation of a new medical diagnostic test as well as to set manufacturing of devices and consumables. The loan obtained recently will allow HemaCore to terminate the scheduled clinical investigations under the project and to enter the European market.
You will have an opportunity to ask your questions directly to the company executives and leading specialists at our exhibition stand in the «Laboratory medicine» hall!
Professor Negrier shared the results of his investigations of the use of Thrombodynamics in patients with hemophilia, and accepted our proposal to join the clinical advisory board of HemaCore LLC.
Resume of the special symposium HemaCore: «Complex approach to therapy with anticoagulants: clinical practice and laboratory control»HOCTOBER 08, 2013 Company news
Last week, our regular event, a symposium dedicated to
the urgent issues of hemostasis diagnostics, took place within the frame of the
exhibition «Interlabdiagnostics – 2013». The leading authorities in the domain
were presiding and speaking at our symposium. The anticoagulant therapy was the
key topic of the event.
The program is dedicated to the medical specialists
and laboratory doctors; it consists of the general theoretical course of
lectures and of clinical workshops oriented to different groups of students.
HemaCore takes part in the IIId International exhibition and conference «Bioindustry» which will take place on October 16-18 in Saint Petersburg.